Abstract
We analyzed the facilitatory effect of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide (mCPBG) on the electrically evoked noradrenaline release in superfused mouse brain tissue. In addition, we determined the affinities of mCPBG and two other 5-HT receptor ligands, namely, 2-methyl-5-hydroxytryptamine (2-methyl-5-HT; also a 5-HT3 receptor agonist) and 5-carboxamidotryptamine (5-CT; a 5-HT1 receptor agonist) for α2 binding sites. The latter two 5-HT receptor agonists were included because of the claimed involvement of α2-adrenoceptors in their effects on noradrenaline release.
In superfusion experiments on mouse brain cortex slices preincubated with 3H-noradrenaline, tritium overflow evoked by 2-min periods of electrical field stimula tion (3 Hz) was facilitated by mCPBG and, in addition, by rauwolscine (α2-adrenoceptor antagonist) and tetraethylammonium (K+ channel blocker) (which were examined for comparison). The effect of mCPBG was not affected by the 5-HT3 receptor antagonist tropisetron or by desipramine but was abolished by rauwolscine. In slices superfused with medium containing desipramine, the concentration-response curve of unlabelled noradrenaline for its inhibitory effect on the electrically (0.3 Hz) evoked overflow was shifted to the right by mCPBG and rauwolscine (apparent pA2 5.35 and 7.88, respectively). In another series of superfusion experiments, 4 electrical pulses, administered at 100 Hz, were used to evoke tritium overflow. Tritium overflow evoked by this stimulation procedure (under which an endogenous tone of noradrenaline does not develop) was not affected by mCPBG and rauwolscine but still increased by tetraethylammonium. The specific binding of 3H-rauwolscine to rat brain cortex homogenates was displaced monophasically by unlabelled rauwolscine, mCPBG, 2-methyl-5-HT and 5-CT (pKi 8.59, 5.84, 5.05 and 5.86, respectively).
In conclusion the present results indicate that mCPBG acts as a low-affinity antagonist at α2-adrenoceptors. This property has to be considered in functional studies of 5-HT3 receptor-mediated effects in tissues containing α2-adrenoceptors as well.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- mCPBG:
-
1-(m-chlorophenyl)-biguanide
- 5-CT:
-
5-carboxamidotryptamine
- 2-methyl-5-HT:
-
2-methyl-5-hydroxytryptamine
- POP:
-
pseudo-one-pulse
- TEA:
-
tetraethylammonium
References
Allgaier C, Feuerstein TJ (1993) 5-HT receptor ligands modulate noradrenaline release in rabbit hippocampus and human neocortex by interacting with presynaptic α2-adrenoceptors. Fund Clin Pharmacol 7:345
Bönisch H, Barann M, Graupner J, Göthert M (1993) Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium. Br J Pharmacol 108:436–442
Bradford MM (1976) Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bylund DB, Blaxall HS, Iversen LJ, Caron MG, Lefkowitz RJ, Lomasney JW (1992) Pharmacological characteristics of α2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol Pharmacol 42:1–5
Cook NS (1988) The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 9:21–28
Fozard JR (1984) Neuronal 5-HT receptors in the periphery. Neuropharmacology 23:1473–1486
Hedler L, Stamm G, Weitzell R, Starke K (1981) Functional characterization of central α-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol 70:43–52
Hoyer D (1990) Serotonin 5-HT3, 5-HT4, and 5-HT LM receptors. Neuropsychopharmacology 3:371–383
Johnson RM, Inouye GT, Eglen RM, Wong EHF (1993) 5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex. Naunyn-Schmiedebergs Arch Pharmacol 347:241–247
Kilpatrick GJ, Tyers MB (1992) The pharmacological properties and functional roles of central 5-HT3 receptors. In: Hamon M (ed) Central and peripheral 5-HT3 receptors. Academic Press, London, pp 33–57
Kilpatrick GJ, Bunce KT, Tyers MB (1990a) 5-HT3 receptors. Med Res Rev 10:441–475
Kilpatrick GJ, Butler A, Burridge J, Oxford AW (1990b) 1-(m-Chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist. Eur J Pharmacol 182:193–197
McPherson GA, Molenaar P, Raper C, Malta E (1983) Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. J Pharmacol Methods 10:231–241
Schlicker E, Fink K, Hinterthaner M, Gothert M (1989) Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn-Schmiedebergs Arch Pharmacol 340:633–638
Schlicker E, Behling A, Lümmen G, Malinowska B, Gothert M (1992) Mutual interaction of histamine H3-receptors and α2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex. Naunyn-Schmiedebergs Arch Pharmacol 345:639–646
Schlicker E, Detzner M, Exner HJ, Gothert M (1993) Blockade of α2-adrenoceptors accounts for the facilitatory effect of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide on noradrenaline release in mouse brain cortex slices. Fund Clin Pharmacol 7:380
Singer EA (1988) Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol Sci 9:274–276
Zifa E, Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401–458
Author information
Authors and Affiliations
Additional information
Correspondence to: E. Schlicker at the above address
Rights and permissions
About this article
Cite this article
Schlicker, E., Kathmann, M., Exner, H.J. et al. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of α2-adrenoceptors in the mouse brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 349, 20–24 (1994). https://doi.org/10.1007/BF00178201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178201